Open-Label Pilot Study of Testosterone Patch Therapy in Men With Opioid-Induced Androgen Deficiency
Open Access
- 31 March 2006
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pain
- Vol. 7 (3), 200-210
- https://doi.org/10.1016/j.jpain.2005.10.009
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Comparison of the Steady-State Pharmacokinetics, Metabolism, and Variability of a Transdermal Testosterone Patch Versus a Transdermal Testosterone Gel in Hypogonadal MenThe Journal of Sexual Medicine, 2005
- Opioids in non-cancer pain: Opioid Induced Androgen Deficiency in men (OPIAD): An estimate of the potential patient population in the U.S. and CanadaThe Journal of Pain, 2004
- Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioidsCancer, 2004
- Testosterone Gel Supplementation for Men With Refractory Depression: A Randomized, Placebo-Controlled TrialAmerican Journal of Psychiatry, 2003
- The Treatment of Chronic Depression, Part 2The Journal of Clinical Psychiatry, 1998
- Altered sexual function and decreased testosterone in patients receiving intraspinal opioidsJournal of Pain and Symptom Management, 1994
- What does the BDI measure in chronic pain?Pain, 1993
- The response to analgesia testing is affected by gonadal steroids in the ratLife Sciences, 1989
- Chronic Morphine Treatment Induces Hypersensitivity to Testosterone-Negative Feedback in Castrated Male RatsNeuroendocrinology, 1985
- Sexual Functioning, Health Beliefs, and Compliance with High Blood Pressure MedicationsNursing Research, 1982